Gilead Sciences
Выбор редакции
28 марта, 15:07

6 Best Biotech Stocks to Watch in 2020

Here is a list of the best biotech stocks. These companies are the future of medicine, and investors are looking to see where to put their money.   The post 6 Best Biotech Stocks to Watch in 2020 appeared first on Investment U.

Выбор редакции
Выбор редакции
30 ноября 2018, 17:56

Key Pharma Players With HIV Focus Ahead of World Aids Day

We take a look at some of the major pharma companies in the HIV market that are developing drugs to address the life-threatening disease.

30 ноября 2018, 17:06

Bayer (BAYRY) to Restructure Business & Reduce Headcount

Bayer (BAYRY) conducts a strategic review of its business model, and plans to exit unprofitable product lines and reduce headcount.

30 ноября 2018, 00:21

Merck (MRK) Receives Approval for 2 HIV Medicines in EU

Merck's (MRK) two new HIV drugs, Pifeltro and Delstrigo, containing doravirine, get approval in EU.

29 ноября 2018, 16:38

Roche (RHHBY) to Acquire Jecure and Enter the NASH Space

Roche (RHHBY) is all set to acquire biotech Jecure Therapeutics, which focuses on the discovery of novel therapeutics for the treatment of NASH and liver fibrosis.

29 ноября 2018, 16:33

Catalyst's Firdapse Receives FDA Approval for Rare Disease

Catalyst's (CPRX) Firdapse gets FDA approval for the treatment of LEMS in adults.

29 ноября 2018, 01:48

Novartis (NVS) Receives EC Approval for Neulasta Biosimilar

Novartis (NVS) obtains EC approval for Ziextenzo, the biosimilar of Amgen's Neulasta.

29 ноября 2018, 01:09

Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity

Pfizer (PFE) receives pediatric exclusivity for its epilepsy drug, Lyrica, extending the exclusivity period to Jun 30, 2019.

29 ноября 2018, 00:07

Celgene & Bluebird's CAR T Therapy Study Completes Enrollment

Celgene (CELG) and partner bluebird complete enrollment in a phase II study for CAR T cell therapy candidate, bb2121 for patients with relapsed and refractory multiple myeloma.

Выбор редакции
28 ноября 2018, 18:22

Aileron Inks Collaboration Deal With Pfizer for Cancer Combo

Aileron Therapeutics (ALRN) signs a clinical trial collaboration contract with Pfizer to study the combo of Aileron's ALRN-6924 and Pfizer's Ibrance for treating MDM2-amplified cancers. Stock rises.

Выбор редакции
28 ноября 2018, 15:14

Компания Roche планирует приобрести фирму Jecure Therapeutics

Швейцарский фармацевт Roche планирует приобрести американскую компанию Jecure Therapeutics с целью расширения бизнеса в сфере производства препаратов для лечения стеатоза печени. Представители компании не уточнили, какую сумму она готова заплатить за американскую фирму. Стоит отметить, что другие крупные представители фармацевтического сектора, в частности, Pfizer, Gilead Sciences и Novartis, в последнее время тоже заключили ряд сделок, направленных на расширение бизнеса в сфере лечения названного выше заболевания.

02 апреля 2018, 22:31

Top Stock Reports for United Technologies, Medtronic & Gilead

Top Stock Reports for United Technologies, Medtronic & Gilead

28 марта 2018, 17:50

Celgene Loses 17.8% in 3 Months: Time to Reshuffle Portfolio?

Things have not been going Celgene's (CELG) way as the company has suffered a series of setbacks. The stock has lost 17.8% in the last three months.

27 марта 2018, 16:54

3 Sell-Rated Drug Stocks Investors Should Avoid for Now

Despite a fairly upbeat performance of the pharma and biotech sector, caution has to be exercised before choosing a stock for investment as a few drug companies are struggling to revive business.

Выбор редакции
18 марта 2018, 14:19

Gilead Sciences' $14 Billion-Per-Year Threat

And the threat could come from Gilead itself.

15 марта 2018, 16:40

Is Gilead Sciences (GILD) a Great Stock for Value Investors?

Let's see if Gilead Sciences Inc. (GILD) stock is a good choice for value-oriented investors right now from multiple angles.

14 марта 2018, 15:13

Cancer Space Takes Giant Strides: Are Patients Benefiting?

The new cancer treatments are probably not doing enough to cure patients or help them live longer or better.